ProShare Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Sell |
43,746
-3,449
| -7% | -$7.97K | ﹤0.01% | 1876 |
|
|
2025
Q1 | $65.6K | Sell |
47,195
-11,881
| -20% | -$16.5K | ﹤0.01% | 1916 |
|
|
2024
Q4 | $102K | Buy |
59,076
+14,418
| +32% | +$24.9K | ﹤0.01% | 2071 |
|
|
2024
Q3 | $89.8K | Buy |
44,658
+33,113
| +287% | +$66.6K | ﹤0.01% | 1899 |
|
|
2024
Q2 | $25.9K | Sell |
11,545
-1,558
| -12% | -$3.49K | ﹤0.01% | 1795 |
|
|
2024
Q1 | $37.6K | Buy |
13,103
+1,157
| +10% | +$3.32K | ﹤0.01% | 1939 |
|
|
2023
Q4 | $21.1K | Buy |
+11,946
| New | +$21.1K | ﹤0.01% | 1916 |
|
|
2022
Q1 | – | Sell |
-10,368
| Closed | -$121K | – | 2301 |
|
|
2021
Q4 | $121K | Buy |
+10,368
| New | +$121K | ﹤0.01% | 2165 |
|